By Professor Bruce Neal

Journal articles

Oshima M; Neal B; Toyama T; Ohkuma T; Li Q; de Zeeuw D; Heerspink HJL; Mahaffey KW; Fulcher G; Canovatchel W; Matthews DR; Perkovic V, 2020, 'Different eGFR decline thresholds and renal effects of canagliflozin: Data from the CANVAS program', Journal of the American Society of Nephrology, 31, pp. 2446 - 2456, http://dx.doi.org/10.1681/ASN.2019121312

Elliott P; Muller DC; Schneider-Luftman D; Pazoki R; Evangelou E; Dehghan A; Neal B; Tzoulaki I, 2020, 'Estimated 24-Hour Urinary Sodium Excretion and Incident Cardiovascular Disease and Mortality among 398628 Individuals in UK Biobank', Hypertension, 76, pp. 683 - 691, http://dx.doi.org/10.1161/HYPERTENSIONAHA.119.14302

Li JW; Neal B; Perkovic V; de Zeeuw D; Neuen BL; Arnott C; Simpson R; Oh R; Mahaffey KW; Heerspink HJL, 2020, 'Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetes', Kidney International, 98, pp. 769 - 777, http://dx.doi.org/10.1016/j.kint.2020.04.051

Egnell M; Neal B; Ni Mhurchu C; Rayner M; Jones A; Seconda L; Touvier M; Kesse-Guyot E; Hercberg S; Julia C, 2020, 'Prospective associations of four nutrient profiles with weigh gain, overweight and obesity risk', European Journal of Public Health, 30, pp. V1009 - V1009, http://dx.doi.org/10.1093/eurpub/ckaa166.1285

Jin A; Liu K; Labarthe DR; Feng X; Zhang R; Wang H; Qiao Q; Li H; Li J; Gao P; Fang H; Duan P; Wang Y; Zhang H; Cao L; Neal B; Chen J; Wu Y, 2020, 'Impact of salt substitute and stepwise reduction of salt supply on blood pressure in residents in senior residential facilities: Design and rationale of the DECIDE-Salt trial', American Heart Journal, 226, pp. 198 - 205, http://dx.doi.org/10.1016/j.ahj.2020.05.013

Thout SR; Yu J; Tian M; Huffman MD; Arnott C; Li Q; Devarsetty P; Johnson C; Pettigrew S; Neal B; Wu JHY, 2020, 'Rationale, design, and baseline characteristics of the Salt Substitute in India Study (SSiIS): The protocol for a double-blinded, randomized-controlled trial', Journal of Clinical Hypertension, 22, pp. 1504 - 1512, http://dx.doi.org/10.1111/jch.13947

Li JW; Han TW; Woodward M; Anderson CS; Zhou H; Chen YD; Neal B, 2020, 'The impact of 2019 novel coronavirus on heart injury: A Systematic review and Meta-analysis', Progress in Cardiovascular Diseases, 63, pp. 518 - 524, http://dx.doi.org/10.1016/j.pcad.2020.04.008

Badve SV; Pascoe EM; Tiku A; Boudville N; Brown FG; Cass A; Clarke P; Dalbeth N; Day RO; De Zoysa JR; Douglas B; Faull R; Harris DC; Hawley CM; Jones GRD; Kanellis J; Palmer SC; Perkovic V; Rangan GK; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW; Neal B, 2020, 'Effects of allopurinol on the progression of chronic kidney disease', New England Journal of Medicine, 382, pp. 2504 - 2513, http://dx.doi.org/10.1056/NEJMoa1915833

Coyle DH; Shahid M; Dunford EK; Mhurchu CN; McKee S; Santos M; Popkin BM; Trieu K; Marklund M; Taylor F; Neal B; Wu JHY, 2020, 'Contribution of major food companies and their products to household dietary sodium purchases in Australia', International Journal of Behavioral Nutrition and Physical Activity, 17, pp. 81, http://dx.doi.org/10.1186/s12966-020-00982-z

LI J; JARDINE MJ; NEAL B; HEERSPINK HL; CANNON C; AGARWAL R; BAKRIS G; CHARYTAN DM; ZEEUW DD; EDWARDS R; GREENE TOM; LEVIN A; POLLOCK CA; ROSENTHAL N; WHEELER DC; ZHANG H; ZINMAN B; PERKOVIC V; MAHAFFEY KW; ARNOTT C, 2020, '27-OR: Effect of Canagliflozin on Total Hospitalization for Heart Failure Events in Patients with Type 2 Diabetes and Chronic Kidney Disease', Diabetes, 69, http://dx.doi.org/10.2337/db20-27-or

Neal B; Marklund M, 2020, 'Is salt substitution ready for prime time?', Nature Reviews Cardiology, 17, pp. 325 - 326, http://dx.doi.org/10.1038/s41569-020-0365-0

Kang A; Neuen B; Heerspink HL; Di Tanna GL; Neal B; Zhang H; Hockham C; Agarwal R; Bakris G; Charytan DM; De Zeeuw D; Greene T; Levin A; Pollock C; Wheeler D; Zinman B; Mahaffey KW; Perkovic V; Jardine M; Lambers Heerspink H, 2020, 'P1013CANAGLIFLOZIN AND RISK OF GENITAL INFECTIONS AND URINARY TRACT INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE- A POST-HOC ANALYSIS OF THE CREDENCE TRIAL', Nephrology Dialysis Transplantation, 35, pp. gfaa142.p1013, http://dx.doi.org/10.1093/ndt/gfaa142.p1013

Kang A; Smyth B; Neuen B; Lambers Heerspink H; Di Tanna GL; Neal B; Zhang H; Hockham C; Agarwal R; Bakris G; Charytan DM; De Zeeuw D; Greene T; Levin A; Pollock C; Wheeler D; Zinman B; Mahaffey KW; Perkovic V; Jardine M, 2020, 'P1019CANAGLIFLOZIN AND RISK OF SKIN AND SOFT TISSUE INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE - A POST-HOC ANALYSIS OF THE CREDENCE TRIAL', Nephrology Dialysis Transplantation, 35, http://dx.doi.org/10.1093/ndt/gfaa142.p1019

Coyle DH; Wu JHY; Di Tanna GL; Shahid M; Taylor F; Neal B; Trevena H, 2020, 'The effects of a supermarket-based intervention on the nutritional quality of private-label foods: A prospective study', Nutrients, 12, pp. 1 - 16, http://dx.doi.org/10.3390/nu12061692

Shahid M; Neal B; Jones A, 2020, 'Uptake of australia’s health star rating system 2014–2019', Nutrients, 12, pp. 1 - 13, http://dx.doi.org/10.3390/nu12061791

Arnott C; Huang Y; Neuen BL; Di Tanna GL; Cannon CP; Oh R; Edwards R; Kavalam M; Rosenthal N; Perkovic V; Jardine MJ; Mahaffey K; Neal B, 2020, 'The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trial.', Diabetes Obes Metab, 22, pp. 1753 - 1766, http://dx.doi.org/10.1111/dom.14091

Bhat S; Marklund M; Henry ME; Appel LJ; Croft KD; Neal B; Wu JHY, 2020, 'A Systematic Review of the Sources of Dietary Salt Around the World', Advances in Nutrition, 11, pp. 677 - 686, http://dx.doi.org/10.1093/advances/nmz134

Jardine MJ; Zhou Z; Mahaffey KW; Oshima M; Agarwal R; Bakris G; Bajaj HS; Bull S; Cannon CP; Charytan DM; De Zeeuw D; Di Tanna GL; Greene T; Heerspink HJL; Levin A; Neal B; Pollock C; Qiu R; Sun T; Wheeler DC; Zhang H; Zinman B; Rosenthal N; Perkovic V, 2020, 'Renal, cardiovascular, and safety outcomes of canagliflozin by baseline kidney function: A secondary analysis of the CREDENCE randomized trial', Journal of the American Society of Nephrology, 31, pp. 1128 - 1139, http://dx.doi.org/10.1681/ASN.2019111168

Heerspink HJL; Li JW; Neal B; de Zeeuw D, 2020, 'Reply: Mediators of the Effects of Canagliflozin on Heart Failure: Central Role of the Cardiorenal Axis', JACC: Heart Failure, 8, pp. 427, http://dx.doi.org/10.1016/j.jchf.2020.02.005

Grimes CA; Khokhar D; Bolton KA; Trieu K; Potter J; Davidson C; Dunford EK; Jan S; Woodward M; Bolam B; Neal B; Nowson C; Webster J, 2020, 'Salt-related knowledge, attitudes and behaviors (KABS) among victorian adults following 22-months of a consumer awareness campaign', Nutrients, 12, pp. 1216, http://dx.doi.org/10.3390/nu12051216

Clemens KK; Woodward M; Neal B; Zinman B, 2020, 'Sex disparities in cardiovascular outcome trials of populations with diabetes: A Systematic Review and Meta-analysis', Diabetes Care, 43, pp. 1157 - 1163, http://dx.doi.org/10.2337/dc19-2257

Marklund M; Singh G; Greer R; Cudhea F; Matsushita K; Micha R; Brady T; Zhao D; Huang L; Tian M; Cobb L; Neal B; Appel LJ; Mozaffarian D; Wu JHY, 2020, 'Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: Modelling study', The BMJ, 369, pp. m824, http://dx.doi.org/10.1136/bmj.m824

Neal B; Arnott C, 2020, 'A Novel Cardioprotective Therapy That Also Improves Glycemia', JAMA - Journal of the American Medical Association, 323, pp. 1349 - 1350, http://dx.doi.org/10.1001/jama.2020.1905

Lappi VM; Mottas A; Sundström J; Neal B; Löf M; Rådholm K, 2020, 'A comparison of the nutritional qualities of supermarket’s own and regular brands of bread in sweden', Nutrients, 12, pp. 1162, http://dx.doi.org/10.3390/nu12041162

Ndanuko RN; Dunford EK; Wu JHY; Raubenheimer D; Neal BC, 2020, 'Changes in sodium levels of processed foods among the International Food and Beverage Association member companies in Australia: 2013–2017', Journal of Food Composition and Analysis, 87, pp. 103405, http://dx.doi.org/10.1016/j.jfca.2019.103405

Ohkuma T; Van Gaal L; Shaw W; Mahaffey KW; de Zeeuw D; Matthews DR; Perkovic V; Neal B, 2020, 'Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program', Diabetes, Obesity and Metabolism, 22, pp. 530 - 539, http://dx.doi.org/10.1111/dom.13920

Huang L; Tian M; Yu J; Li Q; Liu Y; Yin X; Wu JH; Marklund M; Wu Y; Li N; Elliott P; Yan LL; Labarthe DR; Hao Z; Shi J; Feng X; Zhang J; Zhang Y; Zhang R; Zhou B; Li Z; Sun J; Zhao Y; Yu Y; Neal B, 2020, 'Interim effects of salt substitution on urinary electrolytes and blood pressure in the China Salt Substitute and Stroke Study (SSaSS)', American Heart Journal, 221, pp. 136 - 145, http://dx.doi.org/10.1016/j.ahj.2019.12.020

Bikbov B; Purcell C; Levey AS; Smith M; Abdoli A; Abebe M; Adebayo OM; Afarideh M; Agarwal SK; Agudelo-Botero M; Ahmadian E; Al-Aly Z; Alipour V; Almasi-Hashiani A; Al-Raddadi RM; Alvis-Guzman N; Amini S; Andrei T; Andrei CL; Andualem Z; Anjomshoa M; Arabloo J; Ashagre AF; Asmelash D; Ataro Z; Atout MMDW; Ayanore MA; Badawi A; Bakhtiari A; Ballew SH; Balouchi A; Banach M; Barquera S; Basu S; Bayih MT; Bedi N; Bello AK; Bensenor IM; Bijani A; Boloor A; Borzì AM; Cámera LA; Carrero JJ; Carvalho F; Castro F; Catalá-López F; Chang AR; Chin KL; Chung SC; Cirillo M; Cousin E; Dandona L; Dandona R; Daryani A; Das Gupta R; Demeke FM; Demoz GT; Desta DM; Do HP; Duncan BB; Eftekhari A; Esteghamati A; Fatima SS; Fernandes JC; Fernandes E; Fischer F; Freitas M; Gad MM; Gebremeskel GG; Gebresillassie BM; Geta B; Ghafourifard M; Ghajar A; Ghith N; Gill PS; Ginawi IA; Gupta R; Hafezi-Nejad N; Haj-Mirzaian A; Haj-Mirzaian A; Hariyani N; Hasan M; Hasankhani M; Hasanzadeh A; Hassen HY; Hay SI; Heidari B; Herteliu C; Hoang CL; Hosseini M; Hostiuc M; Irvani SSN; Islam SMS; Jafari Balalami N; James SL; Jassal SK; Jha V; Jonas JB; Joukar F; Jozwiak JJ; Neal B; Schutte A, 2020, 'Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017', The Lancet, 395, pp. 709 - 733, http://dx.doi.org/10.1016/S0140-6736(20)30045-3

Huang L; Trieu K; Yoshimura S; Neal B; Woodward M; Campbell NRC; Li Q; Lackland DT; Leung AA; Anderson CAM; Macgregor GA; He FJ, 2020, 'Effect of dose and duration of reduction in dietary sodium on blood pressure levels: Systematic review and meta-analysis of randomised trials', The BMJ, 368, pp. m315, http://dx.doi.org/10.1136/bmj.m315

Jafar TH; Gandhi M; de Silva HA; Jehan I; Naheed A; Finkelstein EA; Turner EL; Morisky D; Kasturiratne A; Khan AH; Clemens JD; Ebrahim S; Assam PN; Feng L; Neal B, 2020, 'A Community-Based Intervention for Managing Hypertension in Rural South Asia.', New England Journal of Medicine, 382, pp. 717 - 726, http://dx.doi.org/10.1056/nejmoa1911965

Cannon CP; Perkovic V; Agarwal R; Baldassarre J; Bakris G; Charytan DM; De Zeeuw D; Edwards R; Greene T; Heerspink HJL; Jardine MJ; Levin A; Li JW; Neal B; Pollock C; Wheeler DC; Zhang H; Zinman B; Mahaffey KW, 2020, 'Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%: Results From the CREDENCE Trial', Circulation, 141, pp. 407 - 410, http://dx.doi.org/10.1161/CIRCULATIONAHA.119.044359

Arnott C; Li Q; Kang A; Neuen BL; Bompoint S; Lam CSP; Rodgers A; Mahaffey KW; Cannon CP; Perkovic V; Jardine MJ; Neal B, 2020, 'Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis', Journal of the American Heart Association, 9, pp. e014908, http://dx.doi.org/10.1161/JAHA.119.014908

Rådholm K; Zhou Z; Clemens K; Neal B; Woodward M, 2020, 'Effects of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes in women versus men', Diabetes, Obesity and Metabolism, 22, pp. 263 - 266, http://dx.doi.org/10.1111/dom.13876

Li JW; Woodward M; Perkovic V; Figtree GA; Heerspink HJL; Mahaffey KW; de Zeeuw D; Vercruysse F; Shaw W; Matthews DR; Neal B, 2020, 'Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes', JACC: Heart Failure, 8, pp. 57 - 66, http://dx.doi.org/10.1016/j.jchf.2019.08.004

Bolton KA; Webster J; Dunford EK; Jan S; Woodward M; Bolam B; Neal B; Trieu K; Reimers J; Armstrong S; Nowson C; Grimes C, 2020, 'Sources of dietary sodium and implications for a state-wide salt reduction program in Victoria, Australia', British Journal of Nutrition, 123, pp. 1165 - 1175, http://dx.doi.org/10.1017/S000711452000032X

Rådholm K; Mottas A; Lappi V-M; Sundström J; Neal B; Mhurchu CN; Löf M, 2020, 'Measuring the healthiness of child-targeted cereals: a study of the FoodSwitch platform in Sweden', Journal of Medical Internet Research, http://dx.doi.org/10.2196/preprints.17780

Arnott C; Li J-W; Cannon CP; Neuen B; Heerspink HL; Neal B; Charytan DM; Agarwal R; Bakris GL; De Zeeuw D; Greene T; Levin A; Pollock C; Chang T; Rosenthal N; Zhang H; Zinman B; Perkovic V; Jardine M; Mahaffey K, 2020, 'THE EFFECTS OF CANAGLIFLOZIN ON HEART FAILURE AND CARDIOVASCULAR DEATH BY BASELINE PARTICIPANT CHARACTERISTICS: ANALYSIS OF THE CREDENCE TRIAL', Journal of the American College of Cardiology, 75, pp. 674, http://dx.doi.org/10.1016/s0735-1097(20)31301-2

Jones A; Neal B; Reeve B; Ni Mhurchu C; Thow AM, 2019, 'Front-of-pack nutrition labelling to promote healthier diets: Current practice and opportunities to strengthen regulation worldwide', BMJ Global Health, 4, pp. e001882, http://dx.doi.org/10.1136/bmjgh-2019-001882

Li JW; Badve SV; Zhou Z; Rodgers A; Day R; Oh R; Lee M; Perkovic V; de Zeeuw D; Mahaffey KW; Fulcher G; Matthews DR; Neal B, 2019, 'The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program', The Lancet Rheumatology, 1, pp. e220 - e228, http://dx.doi.org/10.1016/S2665-9913(19)30078-5

Arnott C; Neal B, 2019, 'Do GLP-1 receptor agonists care if you have heart failure?', Circulation, 140, pp. 1623 - 1625, http://dx.doi.org/10.1161/CIRCULATIONAHA.119.043303

Dunford EK; Ni Mhurchu C; Huang L; Vandevijvere S; Swinburn B; Pravst I; Tolentino-Mayo L; Reyes M; L'Abbé M; Neal BC, 2019, 'A comparison of the healthiness of packaged foods and beverages from 12 countries using the Health Star Rating nutrient profiling system, 2013–2018', Obesity Reviews, 20, pp. 107 - 115, http://dx.doi.org/10.1111/obr.12879

Carcel C; Neal B; Oparil S; Rogers K; Narkiewicz K; Wang JG; Schiffrin EL; Poulter N; Azizi M; Chalmers J, 2019, 'Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension: The Survey of PatIents with treatment ResIstant hyperTension study', Journal of Hypertension, 37, pp. 2216 - 2224, http://dx.doi.org/10.1097/HJH.0000000000002184

Neuen BL; Young T; Heerspink HJL; Neal B; Perkovic V; Billot L; Mahaffey KW; Charytan DM; Wheeler DC; Arnott C; Bompoint S; Levin A; Jardine MJ, 2019, 'SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis', The Lancet Diabetes and Endocrinology, 7, pp. 845 - 854, http://dx.doi.org/10.1016/S2213-8587(19)30256-6

Zhou Z; Jardine M; Perkovic V; Matthews DR; Mahaffey KW; de Zeeuw D; Fulcher G; Desai M; Oh R; Simpson R; Watts NB; Neal B, 2019, 'Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program', Diabetologia, 62, pp. 1854 - 1867, http://dx.doi.org/10.1007/s00125-019-4955-5

Mahaffey KW; Jardine MJ; Bompoint S; Cannon CP; Neal B; Heerspink HJL; Charytan DM; Edwards R; Agarwal R; Bakris G; Bull S; Capuano G; De Zeeuw D; Greene T; Levin A; Pollock C; Sun T; Wheeler DC; Yavin Y; Zhang H; Zinman B; Rosenthal N; Brenner BM; Perkovic V, 2019, 'Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups: Results from the Randomized CREDENCE Trial', Circulation, 140, pp. 739 - 750, http://dx.doi.org/10.1161/CIRCULATIONAHA.119.042007

Jardine MJ; Li N; Ninomiya T; Feng X; Zhang J; Shi J; Zhang Y; Zhang R; Zhang J; Hao J; Perkovic V; Heerspink HL; Wu Y; Yan LL; Neal B, 2019, 'Dietary Sodium Reduction Reduces Albuminuria: A Cluster Randomized Trial', Journal of Renal Nutrition, 29, pp. 276 - 284, http://dx.doi.org/10.1053/j.jrn.2018.10.009

Toyama T; NEUEN B; Jun M; Ohkuma T; Neal B; Jardine M; Heerspink H; Ninomiya T; Wada T; Perkovic V, 2019, 'SAT-298 EFFECT OF SGLT2 INHIBITORS ON CARDIOVASCULAR, RENAL AND SAFETY OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE', Kidney International Reports, 4, pp. s133, http://dx.doi.org/10.1016/j.ekir.2019.05.338

Stanaway JD; Afshin A; Gakidou E; Lim SS; Abate D; Abate KH; Abbafati C; Abbasi N; Abbastabar H; Abd-Allah F; Abdela J; Abdelalim A; Abdollahpour I; Abdulkader RS; Abebe M; Abebe Z; Abera SF; Abil OZ; Abraha HN; Abrham AR; Abu-Raddad LJ; Abu-Rmeileh NME; Accrombessi MMK; Acharya D; Acharya P; Adamu AA; Adane AA; Adebayo OM; Adedoyin RA; Adekanmbi V; Ademi Z; Adetokunboh OO; Adib MG; Admasie A; Adsuar JC; Afanvi KA; Afarideh M; Agarwal G; Aggarwal A; Aghayan SA; Agrawal A; Agrawal S; Ahmadi A; Ahmadi M; Ahmadieh H; Ahmed MB; Aichour AN; Aichour I; Aichour MTE; Akbari ME; Akinyemiju T; Akseer N; Al-Aly Z; Al-Eyadhy A; Al-Mekhlafi HM; Alahdab F; Alam K; Alam S; Alam T; Alashi A; Alavian SM; Alene KA; Ali K; Ali SM; Alijanzadeh M; Alizadeh-Navaei R; Aljunid SM; Alkerwi A; Alla F; Alsharif U; Altirkawi K; Alvis-Guzman N; Amare AT; Ammar W; Anber NH; Anderson JA; Andrei CL; Androudi S; Animut MD; Anjomshoa M; Ansha MG; Antó JM; Antonio CAT; Anwari P; Appiah LT; Appiah SCY; Arabloo J; Aremu O; Ärnlöv J; Artaman A; Aryal KK; Asayesh H; Ataro Z; Ausloos M; Avokpaho EFGA; Awasthi A; Ayala Quintanilla BP; Ayer R; Ayuk TB; Azzopardi PS; Leung J; Pesudovs K; Jha V; Neal B; Boufous S; Sachdev P; Degenhardt L; Schutte A; Maulik PK; Resnikoff S, 2019, 'Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))', The Lancet, 393, pp. e44, http://dx.doi.org/10.1016/S0140-6736(19)31429-1

Perkovic V; Jardine MJ; Neal B; Bompoint S; Heerspink HJL; Charytan DM; Edwards R; Agarwal R; Bakris G; Bull S; Cannon CP; Capuano G; Chu PL; De Zeeuw D; Greene T; Levin A; Pollock C; Wheeler DC; Yavin Y; Zhang H; Zinman B; Meininger G; Brenner BM; Mahaffey KW; Jha V, 2019, 'Canagliflozin and renal outcomes in type 2 diabetes and nephropathy', New England Journal of Medicine, 380, pp. 2295 - 2306, http://dx.doi.org/10.1056/NEJMoa1811744

LI J; BADVE SV; ZHOU Z; OH R; LEE M; PERKOVIC V; ZEEUW DD; MAHAFFEY KW; FULCHER G; MATTHEWS DR; NEAL B, 2019, '1216-P: The Effects of Canagliflozin on Uric Acid and Gout in Patients with Type 2 Diabetes in the CANVAS Program', Diabetes, 68, http://dx.doi.org/10.2337/db19-1216-p

Back to profile page